Dave Weldon will not be the next director of the CDC, after the White House pulled his nomination just hours ahead of a ...

Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.

Mallinckrodt Pharmaceuticals and Endo are in talks over a potential merger worth about $7 billion, according to a report from ...

GoodRx’s brand new CEO, Wendy Barnes, says her job is not so much to fix anything, but to speed up the company’s current ...

Montara Therapeutics has raised $20 million in an expanded seed financing to advance a pipeline of preclinical CNS candidates ...

Amgen has shared additional Phase 3 data for its rare disease drug Uplizna in myasthenia gravis, bolstering the company’s ...

Endpoints Health Tech newsletter wins SABEW award for business journalism, recognized for coverage of healthcare industry ...

Endo to merge with Mallinckrodt in $6.7B deal. Combined revenue expected at $3.6B by 2025. Deal to close in H2 2025.

Canada gives $62M to Entos, Vetter expands in Germany, EU launches Critical Medicines Act, Noramco invests $25M in NJ, plus ...

Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning.

Can Gilead be held accountable for holding back the sale of an HIV drug it allegedly knew was safer than its blockbuster ...

Unlocking manufacturing capacity will be key for Legend Biotech and Johnson and Johnson in achieving their goal of reaching ...